Your browser doesn't support javascript.
loading
Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study.
Bryushkova, Ekaterina A; Skatova, Valeria D; Mutovina, Zinaida Y; Zagrebneva, Alena I; Fomina, Daria S; Kruglova, Tatyana S; Akopyan, Anna A; Strazhesko, Irina D; Lukyanov, Sergey A; Tkacheva, Olga N; Lysenko, Maryana A; Chudakov, Dmitry M.
Affiliation
  • Bryushkova EA; Pirogov Russian National Research Medical University, Moscow, Russia.
  • Skatova VD; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.
  • Mutovina ZY; Lomonosov Moscow State University, Moscow, Russia.
  • Zagrebneva AI; Pirogov Russian National Research Medical University, Moscow, Russia.
  • Fomina DS; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.
  • Kruglova TS; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Akopyan AA; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Strazhesko ID; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Lukyanov SA; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
  • Tkacheva ON; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Lysenko MA; Pirogov Russian National Research Medical University, Moscow, Russia.
  • Chudakov DM; Pirogov Russian National Research Medical University, Moscow, Russia.
PLoS One ; 17(8): e0273340, 2022.
Article in En | MEDLINE | ID: mdl-36001576

Full text: 1 Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Observational_studies Limits: Adult / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Type: Article Affiliation country: RUSSIA

Full text: 1 Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Observational_studies Limits: Adult / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Type: Article Affiliation country: RUSSIA